Javier Guzmán
Impact in
Papers in
-
- Pharmaceutical Economics and Policy 11
- Health Systems, Economic Evaluations, Quality of Life 9
-
- Biotechnology and Related Fields 7
- Global Health and Surgery 3
- Co-authors
- A. L. Ropars (4 shared papers)Mary M. Moran (3 shared papers)Lindsey C. Wu (4 shared papers)Roderik F. Viergever (2 shared papers)Robert Fraser Terry (2 shared papers)Sadie Regmi (1 shared paper)Stephen A. Matlin (1 shared paper)Christine Årdal (1 shared paper)
- Journals
- Health Systems & Reform (4 papers)Journal of Pharmaceutical Policy and Practice (4 papers)BMJ Evidence-Based Medicine (3 papers)BMJ Global Health (2 papers)PLoS Medicine (2 papers)
- Partner nations
- United StatesUnited KingdomIndia
In The Last Decade
Javier Guzmán
29 papers receiving 753 citations
Peers
Comparison fields: 5 of 115
- Business and International Management 31
- Applied Microbiology and Biotechnology 26
- Public Health, Environmental and Occupational Health 290
- Parasitology 59
- Economics and Econometrics 192
Countries citing papers authored by Javier Guzmán
This map shows the geographic impact of Javier Guzmán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Guzmán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Guzmán more than expected).
Fields of papers citing papers by Javier Guzmán
This network shows the impact of papers produced by Javier Guzmán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Guzmán. The network helps show where Javier Guzmán may publish in the future.
Co-authors
The 25 scholars most cited alongside Javier Guzmán, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 252 | |
| 2 | 2009 | 193 | |
| 3 | 2010 | 52 | |
| 4 | 2020 | 44 | |
| 5 | The New Landscape of Neglected Disease Drug Development | 2005 | 43 |
| 6 | 2011 | 34 | |
| 7 | 2021 | 33 | |
| 8 | 2022 | 24 | |
| 9 | The malaria product pipeline: planning for the future | 2007 | 21 |
| 10 | Neglected disease research and development: Is innovation under threat? | 2011 | 18 |
| 11 | 2012 | 18 | |
| 12 | 2021 | 15 | |
| 13 | 2021 | 13 | |
| 14 | 2023 | 12 | |
| 15 | 2020 | 10 | |
| 16 | DFID Zoonoses Report 6. Prioritising the need for new diagnostics, medicine, vaccines and management practices of zoonoses which have significant impact in the developing world. | 2012 | 8 |
| 17 | 2023 | 5 | |
| 18 | 2023 | 4 | |
| 19 | Registering new drugs: the African context. New tools for new times. | 2010 | 4 |
| 20 | 1994 | 3 |
About Javier Guzmán
Javier Guzmán is a scholar working on Economics and Econometrics, Public Health, Environmental and Occupational Health, Finance, Medical Laboratory Technology and Pediatrics, Perinatology and Child Health, having authored 36 papers that have together received 819 indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (11 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers), Biotechnology and Related Fields (7 papers), Global Maternal and Child Health (6 papers), Healthcare Systems and Reforms (5 papers), Global Public Health Policies and Epidemiology (4 papers), Global Health and Surgery (3 papers) and Quality and Safety in Healthcare (3 papers). The work is most often cited by research in Business and International Management (31 citations), Applied Microbiology and Biotechnology (26 citations), Public Health, Environmental and Occupational Health (290 citations), Parasitology (59 citations) and Economics and Econometrics (192 citations). Javier Guzmán has collaborated with scholars based in United States, United Kingdom and India. Frequent co-authors include A. L. Ropars, Mary M. Moran, Lindsey C. Wu, Roderik F. Viergever, Robert Fraser Terry, Sadie Regmi, Stephen A. Matlin, Christine Årdal, John‐Arne Røttingen and Nicole D. Jameson. Their work appears in journals such as Health Systems & Reform, Journal of Pharmaceutical Policy and Practice, BMJ Evidence-Based Medicine, BMJ Global Health and PLoS Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.